Measles outbreak in Northern Central African Republic 3 years after the last national immunization campaign

BMC Infectious Diseases

Ionela Gouandjika-Vasilache²  Rock Ouambita Mabo¹  Jeff Mutombo³  Casimir Manengu⁴  Marilou Pagonendji²  Vianney Tricou² 

[1] Ministère de la Santé Publique, de la Population et de la Lutte contre le SIDA, Bangui, Central African Republic;Institut Pasteur de Bangui, Bangui, Central African Republic;Médecins Sans Frontières Spain, Bangui, Central African Republic;WHO Office, Bangui, Central African Republic

关键词: Supplementary immunization activities;    Central African Republic;    Outbreak;    Measles;   

Others  :  1171020
DOI  :  10.1186/1471-2334-13-103

 received in 2012-07-09, accepted in 2013-02-20,  发布年份 2013

【 摘 要 】

Background

Despite huge efforts to promote widespread vaccination, measles remains an important cause of morbidity and mortality worldwide, especially in African children. In March 2011, an abnormally high number of cases were reported from the Ouham Prefecture, Central African Republic to the national measles case-based surveillance system. In response, reactive vaccination activities were implemented. The aims of this study were to investigate this outbreak and describe the response.

Methods

Measles cases were defined according to WHO recommendations. In the first weeks of the outbreak, blood samples were collected and sent to the Institut Pasteur in Bangui for laboratory confirmation by detection of IgM antibodies against measles virus. In addition, a portion of viral RNA was amplified from 5 IgM positive patient samples and the amplicons were sequenced for phylogenetic analysis.

Results

Between March and September 2011, 723 clinical cases originated from the Ouham Prefecture, including 2 deaths, were reported. Amongst 59 blood samples collected, 49 were positive for the detection of IgM. A high number of self-declared vaccinated subjects (31%) were found amongst the cases. Most of the cases were under 5 years. The causative virus was found to belong to genotype B3.1. In response, 2 sub-national supplementary immunization activities were quickly conducted and limited this outbreak to mainly 2 sub-prefectures.

Conclusions

This outbreak was the largest epidemic of measles in CAR since 2002. Its occurrence, 3 years after the last national immunization campaign, highlights the necessity to pursue efforts and improve and extend immunization programs in order to reach measles elimination goal in Africa.

【 授权许可】

   
2013 Tricou et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Perry RT, Halsey NA: The clinical significance of measles: a review. J Infect Dis 2004, 189(Suppl 1):S4-16.
• [2]CDC: Progress in Global Measles Control, 2000–2010. MMWR Morb Mortal Wkly Rep 2012, 61(04):73-78.
• [3]CDC: Progress toward measles control - African region, 2001–2008. MMWR Morb Mortal Wkly Rep 2009, 58(37):1036-1041.
• [4]Halsey NA: Measles in developing countries. BMJ 2006, 333(7581):1234.
• [5]CDC: Increased transmission and outbreaks of measles - European Region, 2011. MMWR Morb Mortal Wkly Rep 2011, 60(47):1605-1610.
• [6]Measles reported cases. http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tsincidencemea.htm webcite
• [7]WHO-UNICEF estimates of national immunization coverage. http://apps.who.int/immunization_monitoring/en/globalsummary/wucoveragecountrylist.cfm webcite
• [8]WHO: Monitoring progress towards measles elimination. Wkly Epidemiol Rec 2010, 85(49):490-494.
• [9]WHO: New genotype of measles virus and update on global distribution of measles genotypes. Wkly Epidemiol Rec 2005, 80(40)):347-351.
• [10]Kremer JR, Fack F, Olinger CM, Mulders MN, Muller CP: Measles virus genotyping by nucleotide-specific multiplex PCR. J Clin Microbiol 2004, 42(7):3017-3022.
• [11]Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28(10):2731-2739.
• [12]Gouandjika-Vasilache I, Waku-Kouomou D, Ménard D, Beyrand C, Guye F, Ngoay-Kossy JC, Sélekon B, Wild TF: Cocirculation of measles virus genotype B2 and B3.1 in Central African Republic during the 2000 measles epidemic. J Med Virol 2006, 78(7):964-970.
• [13]Siegfried N, Wiysonge CH, Pienaar D: Too little, too late; measles epidemic in South Africa. Lancet 2010, 376(9736):160-160.
• [14]The International Federation of Red Cross and Red Crescent Societieshttp://www.ifrc.org/en/news-and-media/press-releases/africa/chad/chad-red-cross-red-crescent-strengthens-its-activities-in-areas-hit-by-meningitis-measles-and-cholera/ webcite
• [15]The Central Emergency Response Fundhttp://www.unocha.org/cerf/cerf-worldwide/where-we-work/2011/tcd-2011 webcite
• [16]WHO: Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84(35):349-360.